nodes	percent_of_prediction	percent_of_DWPC	metapath
Mebendazole—CYP1A1—chronic obstructive pulmonary disease	0.634	1	CbGaD
Mebendazole—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0541	0.215	CbGbCtD
Mebendazole—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0365	0.145	CbGbCtD
Mebendazole—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0349	0.139	CbGbCtD
Mebendazole—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0311	0.124	CbGbCtD
Mebendazole—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0304	0.121	CbGbCtD
Mebendazole—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0287	0.114	CbGbCtD
Mebendazole—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0182	0.0726	CbGbCtD
Mebendazole—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0172	0.0685	CbGbCtD
Mebendazole—TUBA1A—respiratory system—chronic obstructive pulmonary disease	0.00331	0.105	CbGeAlD
Mebendazole—TUBA1A—connective tissue—chronic obstructive pulmonary disease	0.00291	0.0921	CbGeAlD
Mebendazole—CYP1A1—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.0029	0.0683	CbGpPWpGaD
Mebendazole—TUBA1A—bronchus—chronic obstructive pulmonary disease	0.00272	0.0861	CbGeAlD
Mebendazole—TUBA1A—Pathogenic Escherichia coli infection—LY96—chronic obstructive pulmonary disease	0.00271	0.0639	CbGpPWpGaD
Mebendazole—TUBA1A—smooth muscle tissue—chronic obstructive pulmonary disease	0.00267	0.0843	CbGeAlD
Mebendazole—TUBA1A—trachea—chronic obstructive pulmonary disease	0.00245	0.0773	CbGeAlD
Mebendazole—TUBB4B—respiratory system—chronic obstructive pulmonary disease	0.00221	0.0697	CbGeAlD
Mebendazole—Albendazole—CYP1A1—chronic obstructive pulmonary disease	0.00202	0.327	CrCbGaD
Mebendazole—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00197	0.0465	CbGpPWpGaD
Mebendazole—Albendazole—CYP1A2—chronic obstructive pulmonary disease	0.00195	0.315	CrCbGaD
Mebendazole—TUBB4B—connective tissue—chronic obstructive pulmonary disease	0.00194	0.0614	CbGeAlD
Mebendazole—TUBB4B—bronchus—chronic obstructive pulmonary disease	0.00182	0.0574	CbGeAlD
Mebendazole—TUBB4B—smooth muscle tissue—chronic obstructive pulmonary disease	0.00178	0.0562	CbGeAlD
Mebendazole—TUBA1A—lung—chronic obstructive pulmonary disease	0.00176	0.0556	CbGeAlD
Mebendazole—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00174	0.0411	CbGpPWpGaD
Mebendazole—TUBB4B—Pathogenic Escherichia coli infection—LY96—chronic obstructive pulmonary disease	0.00164	0.0386	CbGpPWpGaD
Mebendazole—TUBB4B—trachea—chronic obstructive pulmonary disease	0.00163	0.0515	CbGeAlD
Mebendazole—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00143	0.0336	CbGpPWpGaD
Mebendazole—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.00141	0.0402	CcSEcCtD
Mebendazole—CYP1A1—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.00132	0.0312	CbGpPWpGaD
Mebendazole—CYP1A1—respiratory system—chronic obstructive pulmonary disease	0.00124	0.039	CbGeAlD
Mebendazole—CYP1A1—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.0012	0.0284	CbGpPWpGaD
Mebendazole—TUBA1A—p73 transcription factor network—SERPINA1—chronic obstructive pulmonary disease	0.0012	0.0283	CbGpPWpGaD
Mebendazole—TUBB4B—lung—chronic obstructive pulmonary disease	0.00117	0.037	CbGeAlD
Mebendazole—Bopindolol—ADRB2—chronic obstructive pulmonary disease	0.0011	0.179	CrCbGaD
Mebendazole—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00103	0.0293	CcSEcCtD
Mebendazole—CYP1A1—bronchus—chronic obstructive pulmonary disease	0.00102	0.0321	CbGeAlD
Mebendazole—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000999	0.0285	CcSEcCtD
Mebendazole—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000994	0.0284	CcSEcCtD
Mebendazole—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000926	0.0264	CcSEcCtD
Mebendazole—CYP1A1—trachea—chronic obstructive pulmonary disease	0.000913	0.0289	CbGeAlD
Mebendazole—CYP1A1—Estrogen Receptor Pathway—CYP1A2—chronic obstructive pulmonary disease	0.000897	0.0211	CbGpPWpGaD
Mebendazole—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.00089	0.0254	CcSEcCtD
Mebendazole—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.000885	0.0253	CcSEcCtD
Mebendazole—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.00088	0.0251	CcSEcCtD
Mebendazole—Ketoprofen—CXCL8—chronic obstructive pulmonary disease	0.000878	0.142	CrCbGaD
Mebendazole—CYP1A1—Oxidative Stress—SOD3—chronic obstructive pulmonary disease	0.000838	0.0198	CbGpPWpGaD
Mebendazole—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000793	0.0226	CcSEcCtD
Mebendazole—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000792	0.0226	CcSEcCtD
Mebendazole—TUBA1A—Pathogenic Escherichia coli infection—TLR4—chronic obstructive pulmonary disease	0.000761	0.0179	CbGpPWpGaD
Mebendazole—CYP1A1—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.00076	0.0179	CbGpPWpGaD
Mebendazole—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000724	0.0171	CbGpPWpGaD
Mebendazole—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000714	0.0204	CcSEcCtD
Mebendazole—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000714	0.0204	CcSEcCtD
Mebendazole—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.0007	0.02	CcSEcCtD
Mebendazole—CYP1A1—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000691	0.0163	CbGpPWpGaD
Mebendazole—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000686	0.0196	CcSEcCtD
Mebendazole—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000674	0.0193	CcSEcCtD
Mebendazole—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000666	0.019	CcSEcCtD
Mebendazole—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000663	0.0189	CcSEcCtD
Mebendazole—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000663	0.0189	CcSEcCtD
Mebendazole—CYP1A1—lung—chronic obstructive pulmonary disease	0.000656	0.0207	CbGeAlD
Mebendazole—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000646	0.0185	CcSEcCtD
Mebendazole—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000642	0.0203	CbGeAlD
Mebendazole—CYP1A1—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000635	0.015	CbGpPWpGaD
Mebendazole—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000628	0.0179	CcSEcCtD
Mebendazole—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000625	0.0178	CcSEcCtD
Mebendazole—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000618	0.0176	CcSEcCtD
Mebendazole—CYP1A1—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000611	0.0144	CbGpPWpGaD
Mebendazole—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000582	0.0166	CcSEcCtD
Mebendazole—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000555	0.0131	CbGpPWpGaD
Mebendazole—CYP1A1—Oxidative Stress—GCLC—chronic obstructive pulmonary disease	0.000546	0.0129	CbGpPWpGaD
Mebendazole—CYP1A1—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.00053	0.0125	CbGpPWpGaD
Mebendazole—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000529	0.0151	CcSEcCtD
Mebendazole—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000528	0.0151	CcSEcCtD
Mebendazole—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000522	0.0149	CcSEcCtD
Mebendazole—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000522	0.0149	CcSEcCtD
Mebendazole—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000511	0.0146	CcSEcCtD
Mebendazole—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000507	0.0145	CcSEcCtD
Mebendazole—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000507	0.0145	CcSEcCtD
Mebendazole—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000504	0.0144	CcSEcCtD
Mebendazole—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000504	0.0144	CcSEcCtD
Mebendazole—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000498	0.0142	CcSEcCtD
Mebendazole—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000498	0.0142	CcSEcCtD
Mebendazole—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000496	0.0142	CcSEcCtD
Mebendazole—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000494	0.0141	CcSEcCtD
Mebendazole—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000493	0.0141	CcSEcCtD
Mebendazole—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000479	0.0137	CcSEcCtD
Mebendazole—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000476	0.0136	CcSEcCtD
Mebendazole—ABCB1—trachea—chronic obstructive pulmonary disease	0.000474	0.015	CbGeAlD
Mebendazole—CYP1A1—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000472	0.0111	CbGpPWpGaD
Mebendazole—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00047	0.0134	CcSEcCtD
Mebendazole—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00047	0.0134	CcSEcCtD
Mebendazole—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00046	0.0131	CcSEcCtD
Mebendazole—TUBB4B—Pathogenic Escherichia coli infection—TLR4—chronic obstructive pulmonary disease	0.000459	0.0108	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000457	0.0108	CbGpPWpGaD
Mebendazole—TUBA1A—p73 transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000456	0.0108	CbGpPWpGaD
Mebendazole—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000444	0.0127	CcSEcCtD
Mebendazole—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00043	0.0101	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—MUC5AC—chronic obstructive pulmonary disease	0.000425	0.01	CbGpPWpGaD
Mebendazole—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000413	0.0118	CcSEcCtD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000408	0.00961	CbGpPWpGaD
Mebendazole—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000402	0.0115	CcSEcCtD
Mebendazole—Rash—Formoterol—chronic obstructive pulmonary disease	0.000402	0.0115	CcSEcCtD
Mebendazole—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000402	0.0115	CcSEcCtD
Mebendazole—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000402	0.0115	CcSEcCtD
Mebendazole—Rash—Montelukast—chronic obstructive pulmonary disease	0.000394	0.0113	CcSEcCtD
Mebendazole—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000394	0.0112	CcSEcCtD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000388	0.00915	CbGpPWpGaD
Mebendazole—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000387	0.011	CcSEcCtD
Mebendazole—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00038	0.0108	CcSEcCtD
Mebendazole—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000379	0.0108	CcSEcCtD
Mebendazole—CYP1A1—Oxidative Stress—HMOX1—chronic obstructive pulmonary disease	0.000378	0.00891	CbGpPWpGaD
Mebendazole—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000374	0.00881	CbGpPWpGaD
Mebendazole—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000367	0.0105	CcSEcCtD
Mebendazole—CYP1A1—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000366	0.00863	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—MUC1—chronic obstructive pulmonary disease	0.000361	0.00852	CbGpPWpGaD
Mebendazole—ABCB1—lung—chronic obstructive pulmonary disease	0.000341	0.0108	CbGeAlD
Mebendazole—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00034	0.00802	CbGpPWpGaD
Mebendazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000332	0.00783	CbGpPWpGaD
Mebendazole—CYP1A1—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000326	0.00769	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CYP1A2—chronic obstructive pulmonary disease	0.000326	0.00769	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—CYP1A2—chronic obstructive pulmonary disease	0.000326	0.00769	CbGpPWpGaD
Mebendazole—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000326	0.00768	CbGpPWpGaD
Mebendazole—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000313	0.00737	CbGpPWpGaD
Mebendazole—CYP1A1—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000305	0.0072	CbGpPWpGaD
Mebendazole—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000301	0.00709	CbGpPWpGaD
Mebendazole—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000281	0.00803	CcSEcCtD
Mebendazole—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000274	0.00784	CcSEcCtD
Mebendazole—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000272	0.0064	CbGpPWpGaD
Mebendazole—CYP1A1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00027	0.00636	CbGpPWpGaD
Mebendazole—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000267	0.00761	CcSEcCtD
Mebendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000264	0.00622	CbGpPWpGaD
Mebendazole—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000261	0.00615	CbGpPWpGaD
Mebendazole—CYP1A1—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.00026	0.00614	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—MUC5AC—chronic obstructive pulmonary disease	0.000257	0.00605	CbGpPWpGaD
Mebendazole—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000255	0.00727	CcSEcCtD
Mebendazole—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000247	0.00583	CbGpPWpGaD
Mebendazole—Ketoprofen—ALB—chronic obstructive pulmonary disease	0.000228	0.0369	CrCbGaD
Mebendazole—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000227	0.00536	CbGpPWpGaD
Mebendazole—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000218	0.00515	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—MUC1—chronic obstructive pulmonary disease	0.000218	0.00515	CbGpPWpGaD
Mebendazole—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000218	0.00622	CcSEcCtD
Mebendazole—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000218	0.00621	CcSEcCtD
Mebendazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000214	0.00504	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	0.000207	0.00489	CbGpPWpGaD
Mebendazole—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000205	0.00586	CcSEcCtD
Mebendazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000205	0.00482	CbGpPWpGaD
Mebendazole—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000199	0.0057	CcSEcCtD
Mebendazole—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000198	0.00567	CcSEcCtD
Mebendazole—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	0.000191	0.0045	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000189	0.00446	CbGpPWpGaD
Mebendazole—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000185	0.00528	CcSEcCtD
Mebendazole—CYP1A1—PPARA activates gene expression—CTGF—chronic obstructive pulmonary disease	0.000176	0.00416	CbGpPWpGaD
Mebendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—chronic obstructive pulmonary disease	0.000173	0.00407	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	0.000167	0.00393	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	0.000161	0.00379	CbGpPWpGaD
Mebendazole—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000161	0.00379	CbGpPWpGaD
Mebendazole—Rash—Prednisone—chronic obstructive pulmonary disease	0.000158	0.00452	CcSEcCtD
Mebendazole—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000158	0.00452	CcSEcCtD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000151	0.00357	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	0.00015	0.00353	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000139	0.00328	CbGpPWpGaD
Mebendazole—CYP1A1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000137	0.00322	CbGpPWpGaD
Mebendazole—CYP1A1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000135	0.00319	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000133	0.00313	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	0.000131	0.00309	CbGpPWpGaD
Mebendazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00013	0.00306	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	0.00013	0.00306	CbGpPWpGaD
Mebendazole—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000128	0.00302	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000124	0.00292	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.000123	0.0029	CbGpPWpGaD
Mebendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—chronic obstructive pulmonary disease	0.000119	0.0028	CbGpPWpGaD
Mebendazole—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000117	0.00275	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000115	0.00271	CbGpPWpGaD
Mebendazole—CYP1A1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000114	0.00268	CbGpPWpGaD
Mebendazole—CYP1A1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000112	0.00264	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	0.000111	0.00262	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	0.000107	0.00252	CbGpPWpGaD
Mebendazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000105	0.00248	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	0.000103	0.00244	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	0.000102	0.0024	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	0.000101	0.00237	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	0.0001	0.00236	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	0.0001	0.00236	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	9.66e-05	0.00228	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	9.61e-05	0.00227	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	9.52e-05	0.00224	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	9.52e-05	0.00224	CbGpPWpGaD
Mebendazole—CYP1A1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	9.48e-05	0.00223	CbGpPWpGaD
Mebendazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	9.43e-05	0.00222	CbGpPWpGaD
Mebendazole—CYP1A1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	9.35e-05	0.0022	CbGpPWpGaD
Mebendazole—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	9.31e-05	0.0022	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	9.04e-05	0.00213	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.97e-05	0.00211	CbGpPWpGaD
Mebendazole—CYP1A1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	8.71e-05	0.00205	CbGpPWpGaD
Mebendazole—CYP1A1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	8.59e-05	0.00203	CbGpPWpGaD
Mebendazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.65e-05	0.0018	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	7.09e-05	0.00167	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	6.88e-05	0.00162	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	6.8e-05	0.0016	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.73e-05	0.00159	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.65e-05	0.00157	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	6.65e-05	0.00157	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—APIP—chronic obstructive pulmonary disease	6.64e-05	0.00157	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	6.46e-05	0.00152	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	6.25e-05	0.00147	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	5.76e-05	0.00136	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.59e-05	0.00132	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.51e-05	0.0013	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.39e-05	0.00127	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	5.3e-05	0.00125	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	5.28e-05	0.00125	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—TP53—chronic obstructive pulmonary disease	5.06e-05	0.00119	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	4.93e-05	0.00116	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.74e-05	0.00112	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.66e-05	0.0011	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.6e-05	0.00108	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.4e-05	0.00104	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.36e-05	0.00103	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.29e-05	0.00101	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GC—chronic obstructive pulmonary disease	4.28e-05	0.00101	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.23e-05	0.000997	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	4.15e-05	0.000979	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.06e-05	0.000958	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.01e-05	0.000945	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.98e-05	0.000938	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.51e-05	0.000829	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	3.42e-05	0.000806	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3.27e-05	0.000771	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.18e-05	0.000749	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—TP53—chronic obstructive pulmonary disease	3.06e-05	0.000721	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.84e-05	0.00067	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.73e-05	0.000643	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	2.61e-05	0.000615	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	2.56e-05	0.000603	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	2.43e-05	0.000574	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.34e-05	0.000551	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.31e-05	0.000545	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.17e-05	0.00051	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.15e-05	0.000508	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.15e-05	0.000506	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.11e-05	0.000497	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.11e-05	0.000497	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.96e-05	0.000462	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.94e-05	0.000458	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.87e-05	0.00044	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.85e-05	0.000435	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.68e-05	0.000397	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.64e-05	0.000386	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.62e-05	0.000382	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.6e-05	0.000377	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.55e-05	0.000366	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.49e-05	0.000351	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.29e-05	0.000305	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.28e-05	0.000301	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.19e-05	0.00028	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.15e-05	0.000271	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.14e-05	0.000268	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.13e-05	0.000266	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.04e-05	0.000245	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ALB—chronic obstructive pulmonary disease	9.6e-06	0.000226	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.56e-06	0.000225	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	9.18e-06	0.000216	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.98e-06	0.000188	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.87e-06	0.000185	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	7.67e-06	0.000181	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	7.33e-06	0.000173	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.33e-06	0.000173	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.95e-06	0.000164	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	4.72e-06	0.000111	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	4.52e-06	0.000107	CbGpPWpGaD
